{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T09:50:15Z","timestamp":1775382615606,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jac\/dkx306","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T12:11:24Z","timestamp":1503576684000},"page":"i36-i42","source":"Crossref","is-referenced-by-count":39,"title":["The discovery of ceftazidime\/avibactam as an anti-Mycobacterium avium agent"],"prefix":"10.1093","volume":"72","author":[{"given":"Devyani","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikant","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moti. L.","family":"Chapagain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooi S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayle N.","family":"Cirrincione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jotam G.","family":"Pasipanodya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawanda","family":"Gumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"key\n\t\t\t\t20171012095353_dkx306-B1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1099\/mic.0.27629-0","article-title":"Genetic analysis of the \u03b2-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to \u03b2-lactam antibiotics","volume":"151","year":"2005","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/jb.172.3.1418-1423.1990","article-title":"Permeability barrier to hydrophilic solutes in Mycobacterium chelonei","volume":"172","year":"1990","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B3","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1128\/AAC.01226-05","article-title":"Crystal structure of the Mycobacterium fortuitum class A \u03b2-lactamase: structural basis for broad substrate specificity","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B4","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1021\/bi701506h","article-title":"Irreversible inhibition of the Mycobacterium tuberculosis \u03b2-lactamase by clavulanate","volume":"46","year":"2007","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkt410","article-title":"Characterization of broad-spectrum Mycobacterium abscessus class A \u03b2-lactamase","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jac\/dks395","article-title":"Is there a place for \u03b2-lactams in the treatment of multidrug-resistant\/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin\/clavulanate","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jac\/dku510","article-title":"\u03b2-Lactamase inhibition by avibactam in Mycobacterium abscessus","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B8","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/bi300508r","article-title":"NXL104 irreversibly inhibits the \u03b2-lactamase from Mycobacterium tuberculosis","volume":"51","year":"2012","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B9","doi-asserted-by":"crossref","first-page":"e1701102","DOI":"10.1126\/sciadv.1701102","article-title":"Ceftazidime-avibactam has potent sterilizing activity against highly drug resistant tuberculosis","volume":"3","year":"2017","journal-title":"Sci Adv"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B10","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1086\/648443","article-title":"Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence\u2014United States, 2013-2015","volume":"65","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/18.1.6","article-title":"\u03b2-Lactam antibiotics and mycobacteria","volume":"18","year":"1986","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0962-8479(95)90557-X","article-title":"Distribution and characterization of \u03b2-lactamases of mycobacteria and related organisms","volume":"76","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B16","first-page":"177","article-title":"\u03b2-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a \u03b2-lactamase-stable antibiotic","volume":"81","year":"1995","journal-title":"Microbios"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0022-3859.65278","article-title":"Antibiotic susceptibility pattern of rapidly growing mycobacteria","volume":"56","year":"2010","journal-title":"J Postgrad Med"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.mimet.2003.10.020","article-title":"Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine","volume":"56","year":"2004","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/AAC.01324-08","article-title":"In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B20","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1021\/ja8029448","article-title":"Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA \u03b2-lactam antibiotics","volume":"130","year":"2008","journal-title":"J Am Chem Soc"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B21","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01355-09","article-title":"Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B22","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1128\/AAC.01761-09","article-title":"Moxifloxacin pharmacokinetics\/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B23","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.02985-15","article-title":"Thioridazine as chemotherapy for Mycobacterium avium complex diseases","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B24","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1093\/jac\/dkx304","article-title":"Linezolid as treatment for pulmonary Mycobacterium avium disease","volume":"72","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B25","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/jac\/dkx305","article-title":"Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease","volume":"72","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B26","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/jac\/dkv170","article-title":"Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B27","volume-title":"ADAPT 5 User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic Systems Analytic Software"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B29","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B30","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/AAC.02854-15","article-title":"Azithromycin dose to maximize efficacy and suppress acquired drug resistance in pulmonary Mycobacterium avium disease","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B31","author":"Ceftazidime-Avibactam for Injection"},{"key":"key\n\t\t\t\t20171012095353_dkx306-B32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jac\/dks523","article-title":"Comparative study of the efficacy and safety of ceftazidime\/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial","volume":"68","year":"2013","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/suppl_2\/i36\/19733496\/dkx306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T18:40:56Z","timestamp":1659379256000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/suppl_2\/i36\/4110805\/The-discovery-of-ceftazidimeavibactam-as-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":32,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2017,9,11]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx306","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,9,1]]}}}